DK1917958T3 - Forbedrede farmaceutiske formuleringer af HIV proteaseinhibitorer - Google Patents

Forbedrede farmaceutiske formuleringer af HIV proteaseinhibitorer

Info

Publication number: DK1917958T3
Authority: DK; Denmark
Prior art keywords: hiv protease; pharmaceutical formulations; protease inhibitors; improved pharmaceutical; improved
Prior art date: 2000-01-19

Application number

DK07121429.0T

Other languages

English (en)

Inventor

Laman Alani

Soumojeet Ghosh

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-19

Filing date

2000-12-01

Publication date

2012-09-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23936923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1917958(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-12-01 Application filed by Abbott Lab filed Critical Abbott Lab

2012-09-24 Application granted granted Critical

2012-09-24 Publication of DK1917958T3 publication Critical patent/DK1917958T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Virology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)

DK07121429.0T 2000-01-19 2000-12-01 Forbedrede farmaceutiske formuleringer af HIV proteaseinhibitorer DK1917958T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48773900A	2000-01-19	2000-01-19
EP00982360A EP1248600B1 (en)	2000-01-19	2000-12-01	Improved hiv protease inhibitors pharmaceutical formulations

Publications (1)

Publication Number	Publication Date
DK1917958T3 true DK1917958T3 (da)	2012-09-24

Family

ID=23936923

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK07121429.0T DK1917958T3 (da)	2000-01-19	2000-12-01	Forbedrede farmaceutiske formuleringer af HIV proteaseinhibitorer
DK00982360T DK1248600T3 (da)	2000-01-19	2000-12-01	Forbedrede farmaceutiske formuleringer
DK10177365.3T DK2269591T3 (da)	2000-01-19	2000-12-01	Forbedrede farmaceutiske formuleringer

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK00982360T DK1248600T3 (da)	2000-01-19	2000-12-01	Forbedrede farmaceutiske formuleringer
DK10177365.3T DK2269591T3 (da)	2000-01-19	2000-12-01	Forbedrede farmaceutiske formuleringer

Country Status (26)

Country	Link
EP (3)	EP2269591B1 (da)
JP (1)	JP4769400B2 (da)
KR (1)	KR100861885B1 (da)
CN (1)	CN100536833C (da)
AT (1)	ATE395049T1 (da)
AU (2)	AU1940501A (da)
BG (1)	BG66112B1 (da)
BR (1)	BR0011864A (da)
CA (1)	CA2395987C (da)
CY (3)	CY1108197T1 (da)
CZ (1)	CZ304118B6 (da)
DE (1)	DE60038899D1 (da)
DK (3)	DK1917958T3 (da)
ES (3)	ES2387579T3 (da)
HK (1)	HK1120213A1 (da)
HU (1)	HU229778B1 (da)
IL (2)	IL150265A0 (da)
MX (1)	MXPA02007097A (da)
NO (1)	NO331400B1 (da)
NZ (1)	NZ519724A (da)
PT (3)	PT2269591T (da)
SI (3)	SI1917958T1 (da)
SK (1)	SK287143B6 (da)
TR (1)	TR201809435T4 (da)
WO (1)	WO2001052821A1 (da)
ZA (1)	ZA200205109B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5767429B2 (ja)	1999-11-12	2015-08-19	アッヴィ・インコーポレイテッド	固体分散剤中の結晶化阻害剤
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
GB0615211D0 (en) *	2006-07-31	2006-09-06	Ge Healthcare Uk Ltd	Asymmetric flouro-substituted polymethine dyes
WO2009019661A1 (en) *	2007-08-07	2009-02-12	Ranbaxy Laboratories Limited	Process for preparation of amorphous lopinavir
WO2012164575A2 (en)	2011-05-27	2012-12-06	Hetero Research Foundation	Amorphous ritonavir co-precipitated
GB201808564D0 (en)	2018-05-24	2018-07-11	Douglas Pharmaceuticals Ltd	Treatments
GB201808563D0 (en)	2018-05-24	2018-07-11	Univ Manchester	Treatments

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US594836A (en) *		1897-11-30		Corner-brace
US5539122A (en)	1989-05-23	1996-07-23	Abbott Laboratories	Retroviral protease inhibiting compounds
US5354866A (en)	1989-05-23	1994-10-11	Abbott Laboratories	Retroviral protease inhibiting compounds
GB8927913D0 (en)	1989-12-11	1990-02-14	Hoffmann La Roche	Amino acid derivatives
DE69130070T2 (de)	1990-11-19	1999-04-29	Monsanto Co., St. Louis, Mo.	Retrovirale protease inhibitoren
CA2056911C (en)	1990-12-11	1998-09-22	Yuuichi Nagano	Hiv protease inhibitors
EP0532466A3 (en)	1991-09-12	1993-06-16	Ciba-Geigy Ag	Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use
AU2871592A (en)	1991-10-11	1993-05-03	Du Pont Merck Pharmaceutical Company, The	Cyclic ureas and analogues useful as retroviral protease inhibitiors
US5413999A (en)	1991-11-08	1995-05-09	Merck & Co., Inc.	HIV protease inhibitors useful for the treatment of AIDS
ES2112880T3 (es)	1991-11-08	1998-04-16	Merck & Co Inc	Inhibidores de la proteasa de vih utiles para el tratamiento del sida.
EP0560268B1 (en)	1992-03-13	1995-01-04	Bio-Mega/Boehringer Ingelheim Research Inc.	Substituted pipecolinic acid derivatives as HIV protease inhibitors
WO1993023368A1 (en)	1992-05-20	1993-11-25	G.D. Searle & Co.	Urea-containing hydroxyethylamine compounds as retroviral protease inhibitors
US5559256A (en)	1992-07-20	1996-09-24	E. R. Squibb & Sons, Inc.	Aminediol protease inhibitors
IS2334B (is)	1992-09-08	2008-02-15	Vertex Pharmaceuticals Inc., (A Massachusetts Corporation)	Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5484926A (en)	1993-10-07	1996-01-16	Agouron Pharmaceuticals, Inc.	HIV protease inhibitors
WO1994014436A1 (en)	1992-12-29	1994-07-07	Abbott Laboratories	Retroviral protease inhibiting compounds
AU7518694A (en)	1993-08-20	1995-03-21	G.D. Searle & Co.	Retroviral protease inhibitors and combinations thereof
IL110752A (en)	1993-09-13	2000-07-26	Abbott Lab	Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en)	1993-10-01	1996-09-24	Abbott Laboratories	Pharmaceutical composition
US5491253A (en)	1993-10-22	1996-02-13	Abbott Laboratories	Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
IL111991A (en) *	1994-01-28	2000-07-26	Abbott Lab	Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
IL129871A (en)	1994-05-06	2003-11-23	Pharmacia & Upjohn Inc	Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
US5567823A (en)	1995-06-06	1996-10-22	Abbott Laboratories	Process for the preparation of an HIV protease inhibiting compound
US6037157A (en)	1995-06-29	2000-03-14	Abbott Laboratories	Method for improving pharmacokinetics
US5914332A (en)	1995-12-13	1999-06-22	Abbott Laboratories	Retroviral protease inhibiting compounds
EP1295874A3 (en) *	1995-12-13	2003-04-02	Abbott Laboratories	Retroviral protease inhibiting compounds
US6160122A (en)	1996-06-28	2000-12-12	Abbott Laboratories	Process for the preparation of a disubstituted thiazole
ZA9710071B (en) *	1996-11-21	1998-05-25	Abbott Lab	Pharmaceutical composition.
DE60042092D1 (de) *	1999-06-04	2009-06-04	Abbott Lab	Arzneizubereitungen enthaltend mindestens einen HIV Preoteaseinhibitor

2000
- 2000-12-01 CZ CZ20022663A patent/CZ304118B6/cs not_active IP Right Cessation
- 2000-12-01 KR KR1020027009316A patent/KR100861885B1/ko active IP Right Grant
- 2000-12-01 TR TR2018/09435T patent/TR201809435T4/tr unknown
- 2000-12-01 WO PCT/US2000/032771 patent/WO2001052821A1/en active IP Right Grant
- 2000-12-01 SI SI200031073T patent/SI1917958T1/sl unknown
- 2000-12-01 DK DK07121429.0T patent/DK1917958T3/da active
- 2000-12-01 MX MXPA02007097A patent/MXPA02007097A/es active IP Right Grant
- 2000-12-01 EP EP10177365.3A patent/EP2269591B1/en not_active Revoked
- 2000-12-01 PT PT101773653T patent/PT2269591T/pt unknown
- 2000-12-01 AU AU19405/01A patent/AU1940501A/en not_active Abandoned
- 2000-12-01 SI SI200031095T patent/SI2269591T1/en unknown
- 2000-12-01 PT PT07121429T patent/PT1917958E/pt unknown
- 2000-12-01 ES ES07121429T patent/ES2387579T3/es not_active Expired - Lifetime
- 2000-12-01 ES ES10177365.3T patent/ES2676151T3/es not_active Expired - Lifetime
- 2000-12-01 JP JP2001552869A patent/JP4769400B2/ja not_active Expired - Lifetime
- 2000-12-01 NZ NZ519724A patent/NZ519724A/en not_active IP Right Cessation
- 2000-12-01 BR BR0011864-8A patent/BR0011864A/pt not_active Application Discontinuation
- 2000-12-01 CA CA002395987A patent/CA2395987C/en not_active Expired - Lifetime
- 2000-12-01 AT AT00982360T patent/ATE395049T1/de active
- 2000-12-01 PT PT00982360T patent/PT1248600E/pt unknown
- 2000-12-01 SK SK1110-2002A patent/SK287143B6/sk not_active IP Right Cessation
- 2000-12-01 DK DK00982360T patent/DK1248600T3/da active
- 2000-12-01 HU HU0302070A patent/HU229778B1/hu not_active IP Right Cessation
- 2000-12-01 CN CNB008184798A patent/CN100536833C/zh not_active Expired - Lifetime
- 2000-12-01 DE DE60038899T patent/DE60038899D1/de not_active Expired - Lifetime
- 2000-12-01 SI SI200030994T patent/SI1248600T1/sl unknown
- 2000-12-01 DK DK10177365.3T patent/DK2269591T3/da active
- 2000-12-01 EP EP00982360A patent/EP1248600B1/en not_active Revoked
- 2000-12-01 IL IL15026500A patent/IL150265A0/xx unknown
- 2000-12-01 ES ES00982360T patent/ES2304990T3/es not_active Expired - Lifetime
- 2000-12-01 EP EP07121429A patent/EP1917958B1/en not_active Revoked
2002
- 2002-06-17 IL IL150265A patent/IL150265A/en active IP Right Grant
- 2002-06-25 ZA ZA200205109A patent/ZA200205109B/xx unknown
- 2002-07-18 NO NO20023455A patent/NO331400B1/no not_active Application Discontinuation
- 2002-08-02 BG BG106976A patent/BG66112B1/bg unknown
2006
- 2006-11-07 AU AU2006235895A patent/AU2006235895B2/en not_active Revoked
2008
- 2008-07-16 CY CY20081100740T patent/CY1108197T1/el unknown
- 2008-11-04 HK HK08112065.7A patent/HK1120213A1/xx not_active IP Right Cessation
2012
- 2012-08-07 CY CY20121100711T patent/CY1112995T1/el unknown
2018
- 2018-07-03 CY CY20181100697T patent/CY1120408T1/el unknown

Also Published As

Publication number	Publication date
NO20023455D0 (no)	2002-07-18
CZ304118B6 (cs)	2013-11-06
WO2001052821A1 (en)	2001-07-26
EP1917958B1 (en)	2012-06-13
JP2003533435A (ja)	2003-11-11
ATE395049T1 (de)	2008-05-15
AU2006235895A1 (en)	2006-11-30
DK2269591T3 (da)	2018-07-16
SI1248600T1 (sl)	2008-08-31
CY1108197T1 (el)	2014-02-12
NZ519724A (en)	2004-07-30
HUP0302070A2 (hu)	2003-09-29
AU2006235895B2 (en)	2009-08-13
MXPA02007097A (es)	2003-01-28
BG66112B1 (bg)	2011-05-31
DE60038899D1 (de)	2008-06-26
EP1248600A1 (en)	2002-10-16
CY1120408T1 (el)	2019-07-10
NO20023455L (no)	2002-09-18
CY1112995T1 (el)	2016-04-13
BR0011864A (pt)	2004-07-20
SI2269591T1 (en)	2018-08-31
PT2269591T (pt)	2018-07-09
ZA200205109B (en)	2003-10-31
SK11102002A3 (sk)	2002-12-03
SK287143B6 (sk)	2010-01-07
CZ20022663A3 (cs)	2002-11-13
HK1120213A1 (en)	2009-03-27
JP4769400B2 (ja)	2011-09-07
KR20020082210A (ko)	2002-10-30
CN1424907A (zh)	2003-06-18
IL150265A0 (en)	2002-12-01
DK1248600T3 (da)	2008-09-08
ES2676151T3 (es)	2018-07-17
TR201809435T4 (tr)	2018-07-23
IL150265A (en)	2015-02-26
NO331400B1 (no)	2011-12-19
ES2304990T3 (es)	2008-11-01
HU229778B1 (hu)	2014-07-28
SI1917958T1 (sl)	2012-10-30
BG106976A (bg)	2003-05-30
PT1917958E (pt)	2012-08-16
EP1917958A3 (en)	2008-08-27
KR100861885B1 (ko)	2008-10-09
EP1917958A2 (en)	2008-05-07
EP2269591A3 (en)	2011-07-27
ES2387579T3 (es)	2012-09-26
PL361396A1 (en)	2004-10-04
EP2269591B1 (en)	2018-04-04
CN100536833C (zh)	2009-09-09
AU1940501A (en)	2001-07-31
EP2269591A2 (en)	2011-01-05
CA2395987A1 (en)	2001-07-26
CA2395987C (en)	2009-12-22
PT1248600E (pt)	2008-08-25
EP1248600B1 (en)	2008-05-14
HUP0302070A3 (en)	2007-02-28

Publication	Publication Date	Title
CY1105237T1 (el)	2010-03-03	Βελτιωμεναι φαρμακευτικαι διαμορφωσεις πepιλαμβανουσαι ritonavir
HK1120213A1 (en)	2009-03-27	Improved hiv protease inhibitors pharmaceutical formulations
CY1120138T1 (el)	2018-12-12	Στερεη φαρμακευτικη μορφη δοσολογιας που περιλαμβανει μια στερεη διασπορα αναστολεα πρωτεασης toy hiv
NO20032613D0 (no)	2003-06-10	Farmasöytisk sammensetning som har en forbedret vannopplöselighet
DK1333810T3 (da)	2008-02-04	Orale selvemulgerende doseringsformuleringer af pyranon-protease-inhibitorer
DE60118148D1 (de)	2006-05-11	Tenside Formulierungen
AR028537A1 (es)	2003-05-14	Hidrazidas y alcoxiamidas inhibidoras de la angiogénesis
UY27033A1 (es)	2002-06-20	Nuevos compuestos para su uso como inhibidores de la proteasa de vih
IT1318654B1 (it)	2003-08-27	Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.